Cardiometabolic Management Essentials for Advanced Practice Providers (APPs)-Hypertension Management Overview

Video Transcription

Video Summary

In this module on hypertension, the speaker discusses various aspects related to hypertension, also known as the silent killer. They highlight the challenges in managing hypertension, as patients often do not experience symptoms and may resist taking medications. The speaker provides statistics on the impact of hypertension, including its contribution to deaths and healthcare costs. They emphasize the importance of diagnosis and adherence to treatment. The speaker explains the different classifications of blood pressure and the goal of keeping it below 130 over 80. They discuss the risk factors for hypertension, both fixed and modifiable. The speaker goes on to explain the pathophysiology of hypertension, including the renin-angiotensin-aldosterone system and the sympathetic nervous system. They also highlight the potential end organ damage that can occur, such as stroke and heart failure. The speaker provides recommendations for diagnosing hypertension, including blood pressure measurements and additional diagnostic tests. They mention lifestyle interventions as the first line of treatment, including weight loss, a healthy diet, reduced sodium intake, increased potassium intake, and physical activity. They also discuss pharmacologic therapies, such as thiazide diuretics, ACE inhibitors, and calcium channel blockers. The speaker suggests strategies to promote blood pressure control, such as patient education, collaboration with other professionals, individualizing treatment regimens, and providing follow-up and reinforcement. They also mention guideline considerations from the ACC/AHA, including screening for white coat hypertension, primary aldosteronism, and prompt treatment for severely elevated blood pressure. Overall, this module provides a comprehensive overview of hypertension and its management.

Keywords

hypertension

silent killer

blood pressure

diagnosis

treatment adherence

risk factors

pharmacologic therapies